Optimizing medications in older adults with cognitive impairment Page 1 646 Canadian Family
Physician | Le Médecin de famille canadien ► Vol 64: SEPTEMBER | SEPTEMBRE 2018 …

Purpose To examine factors associated with prescribing anti-dementia medicines (ADM),
atypical antipsychotics (A-APM), typical antipsychotics (T-APM), anxiolytics and other …

Older adults represent a growing percentage of the American population. The majority of
older adults use multiple medications on a daily basis. Research demonstrates that …

Purpose: Patients with dementia experience high rates of polypharmacy, potentially
inappropriate medication use, and adverse drug events. There is little guidance for clinicians …

Background: Suboptimal prescribing in older psychiatric patients causes iatrogenic
morbidity. The objectives of this study were to compare the prevalence of suboptimal …

Background Older adults living with dementia may have a higher risk of medication toxicity
than those without dementia. Optimising prescribing in this group of people is a critically …

Older Americans comprise 13 percent of the population, but they consume an average of 30
percent of all prescription drugs. Every day, physicians are faced with issues surrounding …

Background Patients with mild cognitive impairment (MCI) may be especially vulnerable to
the side effects of potentially inappropriate medications (PIMs), especially those that impair …

The numbers are daunting: currently 47 million people worldwide are living with dementia,
projected to exceed 130 million by 2050, with dementia care in 2015 estimated at US $818 …

Older adults with dementia commonly have multiple chronic conditions that prompt clinicians
to prescribe medications. While dementia is a life-limiting disease, progression from mild …